Inotersen and severe thrombocytopenia: Two case reports and review

被引：1

作者：

Senin, Loreto Dominguez ^{[1
]}

Garro, Cristina Borrachero ^{[1
]}

Gomez, Ernesto Sanchez ^{[1
]}

Santos-Rubio, Maria Dolores ^{[1
]}

机构：

[1] Hosp Juan Ramon Jimenez, Serv Farm Hosp, Ronda Exterior Norte S N, Huelva 21005, Spain

来源：

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 2022年 / 60卷 / 07期

关键词：

Key words inotersen; thrombocytopenia; amyloidosis; ANTISENSE OLIGONUCLEOTIDES; TRANSTHYRETIN; 2'-O-METHOXYETHYL;

D O I：

10.5414/CP204190

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Hereditary transthyretin amyloidosis (hATTR) is an ultra-rare illness. Inotersen is a 2???-O-methoxyethyl (2???MOE)modified antisense oligonucleotides (ASO) approved in 2018 as a polyneuropathy treatment for adults with hereditary transthyretin amyloidosis stages 1 or 2. Inotersen can produce grade 4 thrombocytopenia as a severe adverse reaction that can lead to potentially fatal hemorrhage complications. We describe our experience in the management of severe thrombocytopenia with inotersen. The onset of the thrombocytopenia and the incidences described in the cases in our hospital are different from that described in the literature. Also, recovery of platelet levels was faster in our patient who was administered human immunoglobulin G, which suggests that there is an immunological component.

引用

页码：311 / 316

页数：6

共 16 条

[1] Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis [J].

Adams, D. ;

Gonzalez-Duarte, A. ;

O'Riordan, W. D. ;

Yang, C. -C. ;

Ueda, M. ;

Kristen, A. V. ;

Tournev, I. ;

Schmidt, H. H. ;

Coelho, T. ;

Berk, J. L. ;

Lin, K. -P. ;

Vita, G. ;

Attarian, S. ;

Plante-Bordeneuve, V. ;

Mezei, M. M. ;

Campistol, J. M. ;

Buades, J. ;

Brannagan, T. H., III ;

Kim, B. J. ;

Oh, J. ;

Parman, Y. ;

Sekijima, Y. ;

Hawkins, P. N. ;

Solomon, S. D. ;

Polydefkis, M. ;

Dyck, P. J. ;

Gandhi, P. J. ;

Goyal, S. ;

Chen, J. ;

Strahs, A. L. ;

Nochur, S. V. ;

Sweetser, M. T. ;

Garg, P. P. ;

Vaishnaw, A. K. ;

Gollob, J. A. ;

Suhr, O. B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) :11-21

[2] Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy [J].

Adams, David ;

Suhr, Ole B. ;

Dyck, Peter J. ;

Litchy, William J. ;

Leahy, Raina G. ;

Chen, Jihong ;

Gollob, Jared ;

Coelho, Teresa .

BMC NEUROLOGY, 2017, 17

[3]

[Anonymous], ORPHAN MAINTENANCE A

[4]

[Anonymous], FICHA TECNICA WAYLIV

[5] Drug-associated thrombocytopenia [J].

Bakchoul, Tamam ;

Marini, Irene .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2018, :576-583

[6] Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis [J].

Benson, M. D. ;

Waddington-Cruz, M. ;

Berk, J. L. ;

Polydefkis, M. ;

Dyck, P. J. ;

Wang, A. K. ;

Plante-Bordeneuve, V. ;

Barroso, F. A. ;

Merlini, G. ;

Obici, L. ;

Scheinberg, M. ;

Brannagan, T. H., III ;

Litchy, W. J. ;

Whelan, C. ;

Drachman, B. M. ;

Adams, D. ;

Heitner, S. B. ;

Conceicao, I. ;

Schmidt, H. H. ;

Vita, G. ;

Campistol, J. M. ;

Gamez, J. ;

Gorevic, P. D. ;

Gane, E. ;

Shah, A. M. ;

Solomon, S. D. ;

Monia, B. P. ;

Hughes, S. G. ;

Kwoh, T. J. ;

McEvoy, B. W. ;

Jung, S. W. ;

Baker, B. F. ;

Ackermann, E. J. ;

Gertz, M. A. ;

Coelho, T. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) :22-31

[7] Liver transplantation and transthyretin amyloidosis [J].

Benson, Merrill D. .

MUSCLE & NERVE, 2013, 47 (02) :157-162

[8] Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial [J].

Brannagan, T. H. ;

Wang, A. K. ;

Coelho, T. ;

Waddington Cruz, M. ;

Polydefkis, M. J. ;

Dyck, P. J. ;

Plante-Bordeneuve, V. ;

Berk, J. L. ;

Barroso, F. ;

Merlini, G. ;

Conceicao, I. ;

Hughes, S. G. ;

Kwoh, J. ;

Jung, S. W. ;

Guthrie, S. ;

Pollock, M. ;

Benson, M. D. ;

Gertz, M. .

EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (08) :1374-1381

[9] The Effects of 2-O-Methoxyethyl Oligonucleotides on Renal Function in Humans [J].

Crooke, Stanley T. ;

Baker, Brenda F. ;

Pham, Nguyen C. ;

Hughes, Steven G. ;

Kwoh, T. Jesse ;

Cai, Danlin ;

Tsimikas, Sotirios ;

Geary, Richard S. ;

Bhanot, Sanjay .

NUCLEIC ACID THERAPEUTICS, 2018, 28 (01) :10-22

[10] The Effects of 2′-O-Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials [J].

Crooke, Stanley T. ;

Baker, Brenda F. ;

Witztum, Joseph L. ;

Kwoh, Jesse ;

Pham, Nguyen C. ;

Salgado, Nelson ;

McEvoy, Bradley W. ;

Cheng, Wei ;

Hughes, Steven G. ;

Bhanot, Sanjay ;

Geary, Richard S. .

NUCLEIC ACID THERAPEUTICS, 2017, 27 (03) :121-129

← 1 2 →